Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

BCS
Home/The Filing Wire/Collegium Pharmaceutical, Inc./ 10-Q

Quarterly Report · 10-Q

Collegium Pharmaceutical, Inc.

COLLNASDAQEQUITYCurrent

Quarterly Report

Filed Aug 6, 2026Accepted Aug 6, 2026, 7:34 AM EDTCIK 1267565Accession 0001628280-26-053851
View company →Permanent SEC source ↗
Share

Company context

Collegium Pharmaceutical is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. Collegium has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions.

Current securities

COLLNASDAQ · EQUITY · Current

Recent company filings

  1. SCHEDULE 13G - filed by INTEGRATED CORE STRATEGIES (US) LLC regarding COLLEGIUM PHARMACEUTICAL, INCAug 24, 2026
  2. Other EventsAug 13, 2026
  3. Results of Operations and Financial Condition · Regulation FD DisclosureAug 6, 2026
  4. SCHEDULE 13G filingJul 31, 2026
  5. 144 filingJul 17, 2026

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.